A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology

Haematologica

Volumn 97, Issue 5, 2012, Pages 696-704

  Thibaut, Julien ^a   Mérieux, Yves ^b   Rigal, Dominique ^b   Gillet, Germain ^a,c  

^a UNIVERSITÉ DE LYON   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Diagnostic assay; HPA 1a; MAIPA; Neonatal alloimmune thrombocytopenia; Peptide aptamers; Platelets

Indexed keywords

HUMAN PLATELET ANTIGEN 1B ANTIBODY; IMMUNOGLOBULIN G; PEPTIDE APTAMER; THIOREDOXIN; THROMBOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; HUMAN; IMMUNOASSAY; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE APTAMER TECHNOLOGY; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, HUMAN PLATELET; APTAMERS, NUCLEOTIDE; BLOOD PLATELETS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOPRECIPITATION; INFANT, NEWBORN; ISOANTIBODIES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84860580956     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.051276     Document Type: Article

References (37)

1. Landau M, Rosenberg N. Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders. Transfusion. 2010;50(3):558-569.
2. Rayment R, Birchall J, Yarranton H, Hewertson J, Allen D, Murphy MF, et al. Neonatal alloimmune thrombocytopenia. BMJ. 2003;327(7410):331-332.
3. Porcelijn L, Van den Akker ES, Oepkes D. Fetal thrombocytopenia. Semin Fetal Neonatal Med. 2008;13(4):223-230.
4. Serrarens-Janssen VM, Semmekrot BA, Novotny VM, Porcelijn L, Lotgering FK, Delemarre FM, et al. Fetal/neonatal alloimmune thrombocytopenia (FNAIT): past, present, and future. Obstet Gynecol Surv. 2008;63(4):239-252.
5. Bessos H, Turner M, Urbaniak SJ. Is there a relationship between anti-HPA-1a concentration and severity of neonatal alloimmune thrombocytopenia? Immunohematol. 2005; 2(3):102-109.
6. Kiefel V, Santoso S, Weisheit M, Mueller- Eckhardt C. Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood. 1987;70 (6):1722-1726.
7. Wautier JL. [Immunologic platelet tests]. Transfus Clin Biol. 2000;7(1):69s-71s.
8. Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, et al. The clearance mechanism of chilled blood platelets. Cell. 2003;112(1):87-97.
9. Karnicki K, Johnson C, St Cyr J, Ericson D, Rao G. Platelet storage solution improves the in vitro function of preserved platelet concentrate. Vox Sang. 2003;85(4):262-266.
10. Porretti L, Marangoni F, Rebulla P, Sirchia G. Frozen platelet plates for platelet antibody detection and cross-match. Vox Sang. 1994;67(1):52-57.
11. Colas P, Cohen B, Jessen T, Grishina I, McCoy J, Brent R. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature. 1996; 380(6574):548-550.
12. Lu Z, Murray KS, Van Cleave V, LaVallie ER, Stahl ML, McCoy JM. Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions. Biotechnology. 1995;13(4):366-372.
13. Colas P, Brent R. The impact of two-hybrid and related methods on biotechnology. Trends Biotechnol. 1998;16(8):355-363.
14. Borghouts C, Kunz C, Groner B. Peptide aptamer libraries. Comb Chem High Throughput Screen. 2008;11(2):135-145.
15. Nouvion AL, Thibaut J, Lohez OD, Venet S, Colas P, Gillet G, Lalle P. Modulation of Nr-13 antideath activity by peptide aptamers. Oncogene. 2007;26(5):701-710.
16. Cammett TJ, Jun SJ, Cohen EB, Barrera FN, Engelman DM, Dimaio D. Construction and genetic selection of small transmembrane proteins that activate the human erythropoietin receptor. Proc Natl Acad Sci USA. 2010; 107(8):3447-3452.
17. Appert A, Nam CH, Lobato N, Priego E, Miguel RN, Blundell T, et al. Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia. Cancer Res. 2009;69(11):4784-4790.
18. Guida E, Bisso A, Fenollar-Ferrer C, Napoli M, Anselmi C, Girardini JE, et al. Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells. Cancer Res. 2008;68 (16):6550-6558.
19. Bardou C, Borie C, Bickle M, Rudkin BB, Colas P. Peptide aptamers for small molecule drug discovery. Methods Mol Biol. 2009;535 (2):373-388.
20. Mallikaratchy P, Tang Z, Kwame S, Meng L, Shangguan D, Tan W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics. 2007(12);6:2230-8.
21. Evans D, Johnson S, Laurenson S, Davies AG, Ko-Ferrigno P, Walti C. Electrical protein detection in cell lysates using high-density peptide-aptamer microarrays. J Biol. 2008;7(1):3.
22. Yang W, Luo D, Wang S, Wang R, Chen R, Liu Y, et al. TMTP1, a novel tumor-homing peptide specifically targeting metastasis. Clin Cancer Res. 2008;14(17):5494-5502.
23. Griffin HM, Ouwehand WH. A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library. Blood. 1995;86(12):4430-4436.
24. Miroux B, Walker JE. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol. 1996;260(3):289-298.
25. Buerger C, Nagel-Wolfrum K, Kunz C, Butz K, Hoppe-Seyler F, et al. Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells. J Biol Chem. 2003;278(39):37610-37621.
26. Kurtz SE, Esposito K, Tang W, Menzel R. Inhibition of an activated Ras protein with genetically selected peptide aptamers. Biotechnol Bioeng. 2003;82(1):38-46.
27. Baines IC, Colas, P. Peptide aptamers as guides for small-molecule drug discovery. Drug Discov Today. 2006;11(7-8):334-341.
28. Kelsch R, Hutt K, Cassens U, Sibrowski W. Semiquantitative measurement of IgG subclasses and IgM of platelet-specific antibodies in a glycoprotein-specific platelet-antigen capture assay. Br J Haematol. 2002;117(1): 141-150.
29. Nguyen XD, Klüter, H. The SASPA (Simultaneous Analysis of Specific Platelet Antibodies) Assay: Implementation and Performance in the Routine Laboratory Use. Transfus Med Hemother. 2006;33(3):254-259.
30. Killie MK, Salma W, Bertelsen E, Skogen B, Husebekk A. Quantitative MAIPA: Comparison of different MAIPA protocols. Transfus Apher Sci. 2010;43(2):149-154.
31. Nguyen XD, Goebel M, Schober M, Klüter H, Panzer S. The detection of platelet antibodies by simultaneous analysis of specific platelet antibodies and the monoclonal antibody-specific immobilization of platelet antigens: an interlaboratory comparison. Tranfusion. 2010;50(7):1429-1434.
32. Allen D, Rigsby P, Bessos H, Berry J, Wilson D, Ouwehand WH, et al. Collaborative study to establish the first international standard for quantitation of anti-HPA-1a. Vox Sang. 2005;89(2):100-104.
33. Bertrand G, Jallu V, Gouet M, Kjaer KM, Lambin P, Husebekk A, et al. Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure. Transfusion 2005;45(8):1319-1323.
34. Bakchoul T, Meyer O, Agaylan A, Bombard S, Bein G, Sachs UJ, et al. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads. Transfusion 2007;47(8):1363-1368.
35. Hayashi T, Amakishi E, Matsuyama N, Yasui K, Furuta RA, Hori Y, et al. Establishment of a cell line panel as an alternative source of platelet antigens for a screening assay of anti-human platelet antibodies. Transfus Med 2011;21(3):199-204.
36. Bakchoul T, Kubiak S, Krautwurst A, Roderfeld M, Siebert HC, Bein G, et al. Lowavidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion 2011; 51(11):2455-2461.
37. Chong W, Metcalfe P, Mushens R, Lucas G, Ouwehand WH, Navarrete CV. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads. Immunohematology. 2011;51(6): 1261-1270.